Cerenion Oy

📍 Oulu, Finland🗓 Founded 2017👥 20 employees💰 Last funded Jun 2023
We provide the AI tools for the analysis of brain function in intensive care. CERENION C-TREND™ offers the first truly objective and practical method to obtain reliable information on the condition and function of the brain. The clinically validated technology can be integrated into EEG-measurement devices and patient monitors as a software feature. CERENION C-TREND™ is a medical device software that works by combining standard EEG measurement with advanced machine learning algorithms and artificial intelligence. The result is a set of easy parameters that aid medical professionals in clinical decision making. The patented technology has the potential of improving both the quality and the cost of intensive care. Cerenion™, Cerenion C-Trend™, C-Trend™ are trademarks of Cerenion Oy. Cerenion technology is covered by Intellectual Property Rights. All rights reserved. © Cerenion Oy 2017.
4
Total investors
2
Early stage
1
Mid stage
1
Late stage
2017
Founded
Investor geography1 country
Finland
3
Investor activity2017–2023 · investors recorded per year
20171201812022120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Cerenion Oy?
Cerenion Oy has 4 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Cerenion Oy last raise funding?
The most recent investment in Cerenion Oy recorded on gritt.io was in June 2023.
When was Cerenion Oy founded?
Cerenion Oy was founded in 2017.
What industry is Cerenion Oy in?
Cerenion Oy operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Cerenion Oy based?
Cerenion Oy is headquartered in Oulu, Finland.